The use of a cannabis spray as part of the treatment plan for certain patients with cancer is taking another step forward with the announcement of continued clinical research by the New South Wales-based Medlab Clinical LTD. The phase I study is being led by Professor Stephen Clarke and has
Science writer Laura Elizabeth Lansdowne interviews cannabis researcher Ethan Russo, MD about the role of terpenes in cannabis composition. From the article: Terpenoids are responsible for the unique aroma of cannabis. These compounds are lipophilic, can permeate lipid membranes, and several are capable of crossing the blood-brain barrier after inhalation.